1. Home
  2. TECX vs SNDL Comparison

TECX vs SNDL Comparison

Compare TECX & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • SNDL
  • Stock Information
  • Founded
  • TECX 2019
  • SNDL 2006
  • Country
  • TECX United States
  • SNDL Canada
  • Employees
  • TECX N/A
  • SNDL N/A
  • Industry
  • TECX
  • SNDL Pharmaceuticals and Biotechnology
  • Sector
  • TECX
  • SNDL Health Care
  • Exchange
  • TECX Nasdaq
  • SNDL Nasdaq
  • Market Cap
  • TECX 334.4M
  • SNDL 319.0M
  • IPO Year
  • TECX 2018
  • SNDL 2019
  • Fundamental
  • Price
  • TECX $23.12
  • SNDL $1.58
  • Analyst Decision
  • TECX Buy
  • SNDL Buy
  • Analyst Count
  • TECX 5
  • SNDL 1
  • Target Price
  • TECX $79.20
  • SNDL $3.25
  • AVG Volume (30 Days)
  • TECX 250.6K
  • SNDL 2.0M
  • Earning Date
  • TECX 08-13-2025
  • SNDL 07-31-2025
  • Dividend Yield
  • TECX N/A
  • SNDL N/A
  • EPS Growth
  • TECX N/A
  • SNDL N/A
  • EPS
  • TECX N/A
  • SNDL N/A
  • Revenue
  • TECX N/A
  • SNDL $645,362,646.00
  • Revenue This Year
  • TECX N/A
  • SNDL $4.70
  • Revenue Next Year
  • TECX N/A
  • SNDL $3.87
  • P/E Ratio
  • TECX N/A
  • SNDL N/A
  • Revenue Growth
  • TECX N/A
  • SNDL 1.30
  • 52 Week Low
  • TECX $13.70
  • SNDL $1.15
  • 52 Week High
  • TECX $61.07
  • SNDL $2.40
  • Technical
  • Relative Strength Index (RSI)
  • TECX 61.33
  • SNDL 74.40
  • Support Level
  • TECX $20.78
  • SNDL $1.36
  • Resistance Level
  • TECX $22.01
  • SNDL $1.29
  • Average True Range (ATR)
  • TECX 1.27
  • SNDL 0.07
  • MACD
  • TECX 0.31
  • SNDL 0.03
  • Stochastic Oscillator
  • TECX 79.20
  • SNDL 87.76

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

Share on Social Networks: